Elutia Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
ELUT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
12510 Prosperity Drive, Suite 370, Silver Spring, Maryland

There are no Buy or Sell transactions made by insiders since 8/21/2023

Elutia Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
HighCape Capital, L.P. Director, 10%+ Owner $13M Jul 30, 2024
HighCape Capital, LLC 10%+ Owner $13M Jul 30, 2024
Birchview Capital, LP 10% Owner in previous filing $3.99M Dec 31, 2023
Elutia PIPE Investment, LP 10%+ Owner $3.46M Sep 21, 2023
Matthew Ferguson Chief Financial Officer $824K Aug 12, 2024
C. Randal Mills PRESIDENT AND CEO, Director $664K Aug 12, 2024
Ronald K. Lloyd PRESIDENT AND CEO, Director $173K Mar 8, 2022
Michelle LeRoux Williams Chief Scientific Officer $146K Aug 12, 2024
Darryl Roberts Evp, Operations & Product Dev. $49.1K Mar 8, 2022
Thomas Englese Chief Commercial Officer $47.7K Mar 8, 2023
Jerome Riebman Chief Medical Officer $36.1K Sep 8, 2022
Peter G. Edwards General Counsel $8.43K Sep 8, 2022
HighCape Partners GP II, LLC 10%+ Owner Dec 22, 2022
Maybelle Jordan Director Jun 6, 2024
Brigid Makes Director Jun 6, 2024
Kevin Rakin Director, 10%+ Owner Jun 6, 2024
Matt Zuga Director, 10%+ Owner Jun 6, 2024
David Colpman Director Jun 6, 2024

Recent Insider Transactions by Companies or Individuals for Elutia Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.